cancer

Zentalis Pharmaceuticals Raises $165 Million in Expanded IPO
Zentalis Pharmaceuticals Raises $165 Million in Expanded IPO
Bloomberg
Zentalis
cancer
oncology
IPOs
Flag link:
Incyte to Test Its Cancer Drug Jakafi as a Treatment for COVID-19
Incyte to Test Its Cancer Drug Jakafi as a Treatment for COVID-19
Motley Fool
cancer
COVID-19
Incyte
Jakafi
Flag link:
AI and cancer care: 3 ways artificial intelligence may transform cancer outcomes
AI and cancer care: 3 ways artificial intelligence may transform cancer outcomes
Pharmaforum
artificial intelligence
machine learning
cancer
oncology
imaging
liquid biopsies
Flag link:
Grail's Next-Gen Multi-Cancer Test Detects 50 Early-Stage Cancers with 93% Accuracy
Grail's Next-Gen Multi-Cancer Test Detects 50 Early-Stage Cancers with 93% Accuracy
BioSpace
Grail
diagnostics
oncology
cancer
Flag link:
Amgen sees no 'significant delays' from pandemic to novel KRAS cancer drug
Amgen sees no 'significant delays' from pandemic to novel KRAS cancer drug
Fierce Biotech
Amgen
KRAS
AMG 510
COVID-19
clinical trials
cancer
Flag link:
Former Shire execs set up shop to take a shot at 'under the radar' cancer target
Former Shire execs set up shop to take a shot at 'under the radar' cancer target
Endpoints
cancer
oncology
Shire
OncoOne
Flag link:
Thermo Fisher & J&J Team Up to Develop Lung Cancer Companion Diagnostic
Thermo Fisher & J&J Team Up to Develop Lung Cancer Companion Diagnostic
BioSpace
JNJ
Janssen
Thermo Fisher
diagnostics
cancer
clinical trials
Flag link:
Vasella helps Numab to CHF22M round ahead of cancer trial start
Vasella helps Numab to CHF22M round ahead of cancer trial start
Fierce Biotech
Numab Therapeutics
clinical trials
cancer
Daniel Vasella
ND021
Flag link:
Could immuno-oncology treatments get a boost from a 64-year-old antipsychotic?
Could immuno-oncology treatments get a boost from a 64-year-old antipsychotic?
Fierce Biotech
cancer
immuno-oncology
prochlorperazine
antipsychotics
drug repurposing
Flag link:
BMS joins with Voluntis to create cancer support app
BMS joins with Voluntis to create cancer support app
Pharmaforum
Bristol-Myers Squibb
Voluntis
cancer
mobile apps
Flag link:
Exact Sciences Acquires 2 Cancer Diagnostic Companies
Exact Sciences Acquires 2 Cancer Diagnostic Companies
Motley Fool
EXACT Sciences
M&A
diagnostics
cancer
Paradigm Diagnostics
Viomics
Flag link:
ORIC Pharma Plans IPO to Test Therapies for Drug-Resistant Cancers
ORIC Pharma Plans IPO to Test Therapies for Drug-Resistant Cancers
Xconomy
ORIC Pharmaceuticals
IPOs
cancer
ORIC-101
Flag link:
Immunocore raises $130M to fund pivotal cancer program
Immunocore raises $130M to fund pivotal cancer program
Fierce Biotech
Immunocore
cancer
Flag link:
Harbour BioMed gets FDA nod to begin clinical trial for HBM4003 in cancer
Harbour BioMed gets FDA nod to begin clinical trial for HBM4003 in cancer
Pharmaceutical Business Review
Harbor BioMed
FDA
HBM4003
clinical trials
solid tumors
cancer
Flag link:
Gilead hungry for 'don't eat me' cancer biotech: reports
Gilead hungry for 'don't eat me' cancer biotech: reports
Fierce Biotech
Gilead Sciences
Forty Seven
cancer
M&A
Flag link:
U.K. Regulatory Advisor Rejects Roche Cancer Drug
U.K. Regulatory Advisor Rejects Roche Cancer Drug
Motley Fool
Roche
UK
NICE
Polivy
cancer
Flag link:
Thymus atlas could spark new treatments for cancer, autoimmune disease
Thymus atlas could spark new treatments for cancer, autoimmune disease
Fierce Biotech
thymus
autoimmune disease
cancer
Flag link:
New Meds Set to Reshape US CNS and oncology Markets
New Meds Set to Reshape US CNS and oncology Markets
Xconomy
CNS
oncology
cancer
Clarivate Analytics
Biohaven
rimegepant
Novartis
OMB-157
Flag link:
AstraZeneca cans cancer pipeline efforts
AstraZeneca cans cancer pipeline efforts
Fierce Biotech
AstraZeneca
earnings
R&D
cancer
oncology
Flag link:
Biopharma’s big bet on cancer is laid bare
Biopharma’s big bet on cancer is laid bare
EP Vantage
cancer
oncology
M&A
licensing
Flag link:

Pages